(Q78330710)

English

Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II

scientific article published on 01 October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Artur Plonowski

3

object named as

Artur Plonowski

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

Patricia Armatis

7

object named as

Patricia Armatis

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

author name string

Ryszard Braczkowski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Jozsef L Varga

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Kate Groot

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Magdalena Krupa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

95

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1735-1745

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of an insulin-like growth factor by osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Metastatic Behavior of Murine Osteosarcoma by Hypophysectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypothalamic hormones and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of IGF-II in human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of insulin-like growth factors-I and -II on the human osteosarcoma cell line OHS-4.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I re

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Transformation of human cells in culture by N-methyl-N'-nitro-N-nitrosoguanidine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: application of a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10865

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/CNCR.10865

Identifiers

10.1002/CNCR.10865

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12365022%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78330710&oldid=2119268182"